|
HS Code |
453414 |
| Cas Number | 15761-39-4 |
| Molecular Formula | C9H17NO5 |
| Molecular Weight | 219.24 g/mol |
| Iupac Name | tert-butyl (2S)-2-amino-3-hydroxypropanoate |
| Synonyms | Boc-Ser-OH, N-(tert-Butoxycarbonyl)-L-serine |
| Appearance | White to off-white powder |
| Solubility | Soluble in water, methanol, and ethanol |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Melting Point | 110-114°C |
As an accredited Boc-L-Serine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-L-Serine is supplied in a 25g amber glass bottle, sealed for moisture protection, with a tamper-evident cap and proper labeling. |
| Shipping | Boc-L-Serine is shipped in tightly sealed containers to protect it from moisture and contamination. It should be kept at room temperature, away from direct sunlight and incompatible substances. Packaging complies with chemical safety regulations, ensuring secure transit. A material safety data sheet (MSDS) is included for safe handling upon delivery. |
| Storage | Boc-L-Serine should be stored in a tightly sealed container under cool, dry conditions, ideally at 2-8°C (refrigerator temperature). Protect the compound from moisture, direct sunlight, and sources of heat. Use in a well-ventilated area and avoid exposure to acids or bases that may cause decomposition of the Boc protecting group. Store away from incompatible materials. |
Applications of Boc-L-Serine in Industrial ManufacturingBoc-L-Serine serves as a key protected amino acid building block in the synthesis of high-value intermediates, active pharmaceutical ingredients, and specialized peptides. Our manufacturing processes focus on maintaining consistent purity to support demanding industrial requirements across regulated sectors and advanced chemical production lines. 1. Peptide API ManufacturingBoc-L-Serine is integral to the solid-phase and solution-phase peptide synthesis workflows in the pharmaceutical industry. Process engineers select Boc as a robust N-terminal protecting group, enabling selective deprotection and efficient sequence assembly. It helps prevent undesirable side reactions during chain elongation, especially for syntheses involving sensitive or hydroxy-containing sequences. Peptide drug manufacturers rely on Boc-L-Serine for producing specific dipeptides, oligopeptides, and peptide APIs used in metabolic disorder treatments, diagnostic reagents, and hormone analogs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Specialty Chemical IntermediatesBoc-L-Serine supports downstream synthesis of chiral intermediates and non-proteinogenic amino acid derivatives. Custom synthesis programs use it for creating building blocks used in high-performance polymers, specialty catalysts, and agrochemical actives. The compound’s hydroxyl functionality and temporary Boc protection facilitate strategized multistep transformations, including selective acylation, esterification, and coupling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Reference Standards ProductionPharmaceutical laboratories use Boc-L-Serine in the synthesis of certified reference standards, process control samples, and analytical markers. Its role ensures traceable purity during the stepwise assembly of standards used for HPLC, mass spectrometry, and peptide quantitation. Reagent manufacturers employ strict identity verification, traceability, and measurement protocols to satisfy regulatory audits and pharmaceutical quality control requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research-Grade Peptide Synthesis KitsProducers of peptide chemistry kits and laboratory consumables source Boc-L-Serine as a pure protected amino acid for academic, biotechnological, and early-stage R&D customers. The material forms a core input in modular peptide synthesis sets, educational peptide assembly kits, and customized reagent packs. The product’s handling and shelf-life stability play a critical role in supporting reliable, reproducible peptide construction experiments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-L-Serine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
For years, our team has worked at every stage of synthetic peptide manufacturing, growing familiar with the specific challenges chemists face in both academia and industry. Among the key amino acid derivatives our facility produces, Boc-L-Serine stands out not just as a building block, but as a daily workhorse for people who expect consistency and purity batch after batch.
Boc-L-Serine, or N-tert-Butyloxycarbonyl-L-serine, enters the lab as a white crystalline powder. Experienced peptide chemists recognize this molecule's distinct structure: the serine backbone offers unique reactivity thanks to its unprotected side-chain hydroxyl group, while the Boc (tert-butoxycarbonyl) group effectively shields the alpha-amino group. This protection proves essential for stepwise peptide assembly using solution-phase and solid-phase protocols.
Our process controls every detail, from temperature regulation during Boc group attachment to crystallization and drying. Each step aims for high purity—residual solvents, moisture, and unreacted precursors can create real headaches down the line. We routinely monitor key markers: chemical purity often surpasses 99%, and optical rotation always matches L-serine’s specification. Peptide labs notice the difference during Fmoc and Boc strategies, relying on both solubility and stability during long, multi-step syntheses.
Many suppliers highlight catalog numbers and technical data sheets filled with analytics. Our daily work rarely revolves around numbers alone. The true value of any building block shows up in practice: will Boc-L-Serine dissolve at the expected rate in DMF or DCM? Does it store well on the shelf, resisting clumping or hygroscopic caking? Have we minimized residual TFA or other acidic contaminants that might sabotage the coupling efficiency? These are judgments that come from batches—thousands of kilos over years—not just from an isolated certificate of analysis.
We often field questions from research groups struggling with batch inconsistencies or unexplained side reactions. Many times, the culprit traces back to trace impurities: oxidized serine, mismatched enantiomers, or debris from suboptimal purification. Our staff tracks these potential pitfalls by maintaining a strict chain of custody for raw materials and using dedicated production lines for protected amino acids to avoid cross-contamination.
Peptide synthesis rarely forgives shortcuts. Boc-L-Serine’s popularity grows from both its classical role and its adaptability. It excels in standard solution-phase methods, where selective deprotection enables targeted coupling without scrambling side chains. Researchers working with orthogonally protected peptides appreciate that its Boc group resists common Fmoc removal conditions, and the serine side chain stays intact under basic and mild acidic treatments. Solid-phase peptide synthesis (SPPS) protocols benefit by producing cleaner products using our Boc-L-Serine, helped by low residual moisture and high powder flowability.
The biotech sector demands even stricter controls. During scale-up, minor impurities can multiply into major process interruptions. Our experience scaling Boc-L-Serine production has highlighted this countless times. Effective drying, verified residual solvent content, and particle size homogeneity prove crucial—attributes that each lab likely checks during the first trial run of a new supplier, and which have become non-negotiable standards in our own plant.
Some labs focus only on HPLC purity numbers. Yet repeated feedback from industry partners shows that uniformity in melting range, bulk density, and water content can make or break a multi-step production run. Moisture uptake can prompt decomposition during storage, and inconsistent particle size can slow dissolution—a real pain when time is short, or automated systems require specific input conditions.
We’ve tackled these practical issues by refining our drying and milling lines. Close relationships with universities and contract manufacturing organizations have exposed us to a wide spectrum of applications. From vaccine manufacturing to cosmetic peptides, reliability in Boc-L-Serine means not just “high purity,” but predictability batch after batch against any new impurity challenge that may turn up in regulatory filings or failed coupling reactions.
Chemists often weigh the use of Boc-L-Serine against other protected forms—most commonly Fmoc-L-Serine and unprotected L-Serine. While Fmoc-L-Serine sees extensive use in modern SPPS due to milder deprotection profiles and compatibility with automated synthesizers, Boc protection offers a unique set of advantages in specialized workflows.
Fmoc-L-Serine removal relies on base conditions, favoring fast synthesis with minimal acid handling. Boc-protected forms, like our Boc-L-Serine, serve best where harsher acid-labile protection allows tandem removal steps or sequencing workflows that exclude Fmoc transient base exposure. This compatibility suits peptide sequences featuring acid-sensitive modifications, or protocols demanding orthogonality—where the presence of multiple, independently removable groups helps avoid unwanted side-chain modifications or linkage errors.
Over the years, we’ve run collaborative tests with synthetic peptide users comparing coupling yields and side reactions between Boc- and Fmoc-based protocols. For long or difficult sequences with sensitive residues, Boc-L-Serine tends to offer cleaner stepwise progress. Our customers point to fewer byproducts, crisper analysis, and less troubleshooting during downstream purification—especially when a well-controlled Boc group release is necessary.
Industry practitioners face pressures both from project timelines and regulatory expectations. Boc-L-Serine brings with it some inherent challenges, notably its sensitivity to strong acids and potential for side reactions if handled carelessly. Unlike generic trading companies, we’ve invested in operator training and strict batch logging precisely because small details impact real-world performance. Residual acid neutralization, rapid sample collection at every filter, and trace moisture checks are daily best practices in our facility.
Another recurring concern is batch-to-batch variability, which can derail research and commercial projects alike. Many researchers describe the disruption caused by switching suppliers and encountering unexpected performance shortfalls: longer dissolution times, colored residues, or unexplained coupling failures. Continuous improvement in our workflow—supported by real-world feedback—lets us spot these warning signs early. This keeps labs operating without unnecessary delays or resource waste chasing purity problems that start at the raw material source.
Boc-L-Serine’s reliability enables more than just peptide synthesis. Specialists in peptide-mimetic research, cell signaling pathway modulations, and pharmaceutical lead optimization regularly explore serine’s reactivity, harnessing both its nucleophilicity and its potential for further functionalization after Boc removal. Demand from the field of drug design increasingly relies on both known and novel protected derivatives—projects incorporating nonstandard amino acids, backbone modifications, or post-synthetic transformations depend on robust, predictable materials. Every gram that leaves our plant stands on this experience: we understand not just what Boc-L-Serine is supposed to do, but why researchers need unwavering quality.
On the regulatory front, documented traceability has become a core requirement. We respond with comprehensive batch history, stability data, and impurity profiles available on request. We anticipate future shifts in international requirements, updating our manufacturing and testing protocols as needed, and participating in industry discussions on best practices to support regulatory acceptance of peptide-based therapeutics.
Safety and sustainability endure as ongoing concerns in chemical synthesis. Boc group chemistry produces specific waste streams, particularly during deprotection steps. Our plant management commits to reducing VOC emissions, recycling process solvents, and continuously optimizing filtration and recovery to limit environmental impact. Working in peptide chemistry rarely means large-scale emissions compared to other chemical sectors, but reputational trust rides on transparency and improved safety every year.
Worker safety gets attention beyond compliance. Our standard operating procedures include rigorous PPE, focused handler training, and regular audits. These protocols prevent both contamination and exposure, ensuring the purity of Boc-L-Serine and the well-being of everyone involved in its creation. As our experience builds, so do our risk mitigations—our people bring decades of hands-on insight to both the plant floor and the customer’s application.
Our manufacturing mindset differs from that of simple resellers. We know researchers push boundaries at all scales, from mg-quantity experiments to kg-level preclinical campaigns. That means flexible batch sizes, made-to-order scheduling, and the capacity to ramp up production without sacrificing tight controls. Direct customer support from those who know both chemistry and practice equips research teams to troubleshoot challenges quickly and make new discoveries without hesitation.
We routinely coordinate with global academic and industrial partners to forecast demand changes driven by new therapeutic avenues, including peptide vaccines, imaging probes, and functionalized biomaterials. Through practical experience, we have learned that the value of Boc-L-Serine doesn’t stop with its current generation of users—novel delivery systems and post-synthetic modifications will further elevate its importance as a core synthetic tool. Our manufacturing lines adapt with these movements, scaling and refining processes years ahead of peak demand, guided by both customer feedback and our own R&D efforts.
Our process engineers and formulation specialists occasionally step into the lab with customers for troubleshooting and pilot runs. Through these collaborations, several practical tricks for getting the best out of Boc-L-Serine have crystallized:
Years of experience confirm that routine vigilance during handling, and rapport with your manufacturer, surpass almost any specification. We encourage open feedback. From managing supply during global disruptions to troubleshooting a new synthesis route, sharing firsthand data between lab and plant enables true partnership.
Over time, every peptide manufacturer faces supply challenges. Switching suppliers or troubleshooting inconsistent products sets projects back, wastes resources, and frustrates skilled chemists. We’ve built our service model to anchor trust through direct communication, technical backup, and ongoing improvement—every new customer inquiry reads as a challenge to perform better, not as a sales opportunity.
This product’s reliability saves more than just reagent costs. High-purity, stable, and flowable Boc-L-Serine reduces failed experiments, minimizes purification demands, and streamlines the design cycle for therapeutic development. We support our customers as peers who understand the pressures of lab-scale discovery and commercial production alike. That outlook means we work neither as commodity traders nor as distant suppliers, but as manufacturers whose reputation and technical commitment stay measurable in lab results, not just in certificates or glossy catalogs.
Quality isn’t static. Every year brings changes in market requirements, raw material sources, and application protocols. We approach every feedback report—whether from tangled synthesis resin or new regulatory hurdles—as a real opportunity for improvement. An open data stream from every batch run lets us spot subtle shifts in impurity trends, mechanical performance, or handling needs.
Our technical support staff and production engineers work alongside one another, tying together long-standing process expertise with emerging analytical technology. The team stays in tune with academic trends, publication data, and evolving standards for amino acid derivatives. We share this experience directly with users, not just as technical documents, but through dialogue and collaborative troubleshooting.
Boc-L-Serine’s significance goes beyond being just one protected amino acid among many. Our hands-on experience confirms that clear, repeatable performance under laboratory and industrial conditions delivers advantages for those engaged in peptide synthesis, pharmaceutical research, or custom manufacturing. By maintaining full control of the production process, refining methods based on visible needs, and always listening to customer feedback, we support innovation and reliable results where they matter most. Each batch, from the drum to the laboratory bench, reflects our commitment to user success at every step of the synthesis journey.